調査・レポート
2026年9月24日•1分で読めます
Early Menopause Linked to Faster Cognitive Decline and Earlier Alzheimer’s Diagnosis, Study Finds
A joint UCSF and Rush University study of 2,603 women found that earlier menopause is associated with accelerated cognitive decline and earlier onset of Alzheimer’s disease.
調査・レポート
2026年9月17日•1分で読めます
Bill Gates Highlights Irreplaceable Human Care in Alzheimer’s Context
Bill Gates reflects on his father’s Alzheimer’s care, emphasizing the human element that cannot be replaced by robots.
調査・レポート
2026年9月13日•1分で読めます
Hormone Therapy Linked to 16% Lower Alzheimer Risk in Postmenopausal Women, UK Study Finds
A UK study of over 180,000 postmenopausal women found hormone therapy users had a 16% reduced risk of Alzheimer’s disease over a 13‑year follow‑up.
調査・レポート
2026年9月4日•1分で読めます
Dong-A ST Presents Nonclinical Data on GPX4 Activator DA-7505 and Tau Inhibitor DA-7503 at AAIC
Dong-A ST disclosed nonclinical results for its Alzheimer’s drug candidates targeting ferroptosis (DA-7505) and tau aggregation (DA-7503) at the AAIC in London.
調査・レポート
2026年8月30日•1分で読めます
Korean Institute Develops 6‑Stage Prognostic System for Alzheimer’s Progression
Korea's National Institute of Health created a six‑stage risk model for Alzheimer’s disease progression using domestic elderly dementia cohort data, published in Nature Communications.